Perioperative management policies for antithrombotic agents in urological surgery are highly variable, highlighting the need for standardized guidelines.
No takes yet. Share an insight, caveat, or question.
Marked variation in antithrombotic continuation across urological procedures signals inconsistent practice; leaves open the need for prospective studies and consensus guidelines.
Davis et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: